Orsus Xelent Technologies Inc.

Orsus Xelent Technologies Inc. engages in designing, manufacturing, and distributing cellular phones for retail and wholesale distribution in the People's Republic of China. It offers cell phones for global system for mobile communications and code division multiple access platforms to a range of customers and dealers, such as ordinary users, tailored operators, and specialized users from various fields of business and government. The company sells its products to provincial and national sales distributors and dealers. It has strategic partnerships with CEC Mobile Co., Ltd.; Beijing Xingwang Shidai Tech & Trading Co., Ltd.; and CECT-Chinacom Communications Co., Ltd. The company was formerly Universal Flirts Corp. and changed its name to Orsus Xelent Technologies Inc. in April 2005. Orsus Xelent Technologies Inc. was founded in 2004 and is headquartered in Beijing, the People's Republic of China.

Orsus Xelent Technologies Inc. trades as ORSX on OTC. The company is classified in Technology / Communication Equipment and reports in USD.

The current profile places the business in Communication Equipment. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $24.41M of revenue and -$47.39M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Orsus Xelent Technologies Inc. can be compared against peers such as CyberKey Solutions, Inc., DSG Global Inc., EdgeTech International, Inc., Electronic Tele-Communications, Inc., FiberCore, Inc., AS-IP Tech, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $600, beta of 3.98, and return on equity of +1043.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ORSX currently shows total debt of $10.03M and beta of 3.98. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: http://www.orsusxelent.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.